Courage Unmasked
Two extraordinary scientists, Lingbing Zhang and Suzanne Kennedy, share their revolutionary approach to treating cancer cachexia, a deadly wasting syndrome that affects 80% of stage four cancer patients and causes 30% of cancer deaths despite receiving almost no attention in mainstream treatment. * Personal journeys led both scientists to study cachexia - Kennedy after losing a childhood friend to leukemia and Zhang through his fascination with immunology * Cachexia is not simply weight loss but an immune disorder causing the body to destroy itself * Unlike popular belief, increased caloric intake cannot reverse cachexia * 30% of cancer patients die from cachexia rather than their primary cancer * Nearly all pancreatic cancer patients have had cachexia for a year when first diagnosed * The scientists left prestigious positions to found Akexis, developing the first drug targeting the immune dysfunction driving cachexia * Their treatment could revolutionize cancer care by allowing anti-tumor treatments to work more effectively * The drug has completed preclinical work and proof of concept trials with promising results * Their team includes renowned cancer researchers from Cedars-Sinai and Rush University To learn more about their groundbreaking work or support their mission, visit akexis.com Ready to optimize culture and transform engagement? Visit https://commix.io [https://commix.io] to learn more. Commix.io [https://commix.io] AI Culture Optimization software to help leaders get organizational health insights in real-time. Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you. Read to optimize culture and Transform employee engagement? Visit Commix.io [https://commix.io]
14 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Courage Unmasked!